[
  {
    "ts": null,
    "headline": "Goldman Sachs Initiates Coverage of Molina Healthcare (MOH) with Neutral Recommendation",
    "summary": "Goldman Sachs Initiates Coverage of Molina Healthcare (MOH) with Neutral Recommendation",
    "url": "https://finnhub.io/api/news?id=fa4e082ccf0b6fc87b8d110d529fadc1b12e69359f34f2968b01d8eedbf9e418",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760450789,
      "headline": "Goldman Sachs Initiates Coverage of Molina Healthcare (MOH) with Neutral Recommendation",
      "id": 137076768,
      "image": "",
      "related": "MOH",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fa4e082ccf0b6fc87b8d110d529fadc1b12e69359f34f2968b01d8eedbf9e418"
    }
  },
  {
    "ts": null,
    "headline": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
    "summary": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=2ebafd97b3f452ba76aa9b1bb83ace1e15f93b45b9a82cd00840371fa4680557",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760449459,
      "headline": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
      "id": 137085630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MOH",
      "source": "Yahoo",
      "summary": "AMD upgraded, Micron downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=2ebafd97b3f452ba76aa9b1bb83ace1e15f93b45b9a82cd00840371fa4680557"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Research Further and 2 We Find Risky",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 8.6% has lagged the S&P 500’s 22.9% climb.",
    "url": "https://finnhub.io/api/news?id=76a94b44f60a66afa0c94d601551a8e4924ca352f779f40df076c43c7db81684",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760416553,
      "headline": "1 Healthcare Stock to Research Further and 2 We Find Risky",
      "id": 137086030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MOH",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 8.6% has lagged the S&P 500’s 22.9% climb.",
      "url": "https://finnhub.io/api/news?id=76a94b44f60a66afa0c94d601551a8e4924ca352f779f40df076c43c7db81684"
    }
  }
]